Hemorrhagic Fever
Researchers from University of Maryland detail new studies and findings in the area of hemorrhagic fever
Published in TB and Outbreaks Week, September 18th, 2007
"Strains of each of the 4 DV serotypes, attenuated by passage in tissue culture or by recombinant DNA technology, have been formulated into tetravalent vaccines and have entered successful phase 1 and 2 clinical trials in the United States and Southeast Asia. Antibody-dependent enhancement of wild-type DV infections by the vaccine represents a unique safety issue, which...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Lung Cancer
Knee arthritis link to lung cancer - HIV/AIDS Co-Infection Clinical Trial
Research findings from Johns Hopkins Medical Institutions update understanding of HIV/AIDS co-infection clinical trial - HIV/AIDS Co-Infection Risk Factors
Research from Johns Hopkins University in the area of HIV/AIDS co-infection risk factors described - HIV/AIDS Co-Infection Therapy
Studies from R. Zachariah and co-researchers update current data on HIV/AIDS co-infection therapy - HIV/AIDS Co-Infection Vaccines
Study results from University of Oxford, Weatherall Institute of Molecular Medicine update understanding of HIV/AIDS co-infection vaccines - Tuberculosis
Data on tuberculosis described by C.M. Kettunen et al - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
